Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation

A Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options. In this episode, we talk to Dr. Francine Foss of Yale University to break down what CTCL is, how to manage side effects, and the latest advancements in treatment—including promising immunotherapies like CAR T-cell therapy and bispecific antibodies. We also discuss the critical role of clinical trials in shaping the future of CTCL care.

Mentioned on this episode:

• Cutaneous T-cell Lymphoma Fact Sheet
• Recent LLS T-cell lymphoma webcast
• LLS Clinical Trial Support Center
• ClinicalTrials.gov
• Stem cell transplantation
• CAR T-cell therapy
• Bispecific antibodies – Immunotherapy fact sheet

Additional LLS Support Resources:

• Free Nutrition Consultations
• Information Specialists
• Financial support
• Free telephone/web patient programs
• Free booklets
• Young Adult Resources
• Online chats
• Support groups
• Caregiver support
• Caregiver Workbook
• Advocacy and Public Policy
• Survivorship Workbook
• LLS Community
• Mental Health Resources

Supported by Kyowa Kirin, Inc.

The post Cutaneous T-Cell Lymphoma (CTCL): From Diagnosis to Innovation first appeared on The Bloodline with Blood Cancer United Podcast.